Associations of Perioperative Variables With the 30-Day Risk of Stroke or Death in Carotid Endarterectomy for Symptomatic Carotid Stenosis.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 19 11 2019
medline: 9 4 2020
entrez: 19 11 2019
Statut: ppublish

Résumé

Background and Purpose- This analysis was performed to assess the association between perioperative and clinical variables and the 30-day risk of stroke or death after carotid endarterectomy for symptomatic carotid stenosis. Methods- Individual patient-level data from the 5 largest randomized controlled carotid trials were pooled in the Carotid Stenosis Trialists' Collaboration database. A total of 4181 patients who received carotid endarterectomy for symptomatic stenosis per protocol were included. Determinants of outcome included carotid endarterectomy technique, type of anesthesia, intraoperative neurophysiological monitoring, shunting, antiplatelet medication, and clinical variables. Stroke or death within 30 days after carotid endarterectomy was the primary outcome. Adjusted risk ratios (aRRs) were estimated in multilevel multivariable analyses using a Poisson regression model. Results- Mean age was 69.5±9.2 years (70.7% men). The 30-day stroke or death rate was 4.3%. In the multivariable regression analysis, local anesthesia was associated with a lower primary outcome rate (versus general anesthesia; aRR, 0.70 [95% CI, 0.50-0.99]). Shunting (aRR, 1.43 [95% CI, 1.05-1.95]), a contralateral high-grade carotid stenosis or occlusion (aRR, 1.58 [95% CI, 1.02-2.47]), and a more severe neurological deficit (mRS, 3-5 versus 0-2: aRR, 2.51 [95% CI, 1.30-4.83]) were associated with higher primary outcome rates. None of the other characteristics were significantly associated with the perioperative stroke or death risk. Conclusions- The current results indicate lower perioperative stroke or death rates in patients operated upon under local anesthesia, whereas a more severe neurological deficit and a contralateral high-grade carotid stenosis or occlusion were identified as potential risk factors. Despite a possible selection bias and patients not having been randomized, these findings might be useful to guide surgeons and anesthetists when treating patients with symptomatic carotid disease.

Identifiants

pubmed: 31735137
doi: 10.1161/STROKEAHA.119.026320
pmc: PMC7135878
mid: NIHMS1549081
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3439-3448

Subventions

Organisme : Medical Research Council
ID : G0300411
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U01 NS080168
Pays : United States

Références

J Vasc Surg. 1998 Apr;27(4):595-605
pubmed: 9576071
Lancet. 2016 Mar 26;387(10025):1305-11
pubmed: 26880122
J Vasc Surg. 2013 Mar;57(3):619-626.e2; discussion 625-6
pubmed: 23237679
Stroke. 2017 Apr;48(4):955-962
pubmed: 28283609
Dtsch Arztebl Int. 2013 Jul;110(27-28):468-76
pubmed: 23964303
JAMA Neurol. 2015 Jan;72(1):73-80
pubmed: 25383418
Stroke. 2013 Dec;44(12):3394-400
pubmed: 24135929
Stroke. 2012 Jul;43(7):1865-71
pubmed: 22496334
J Stroke Cerebrovasc Dis. 2006 May-Jun;15(3):114-20
pubmed: 17904062
J Vasc Surg. 2017 Dec;66(6):1735-1748.e1
pubmed: 28666824
Eur Heart J. 2011 Nov;32(22):2851-906
pubmed: 21873417
Stroke. 2006 Feb;37(2):344; author reply 344
pubmed: 16397168
Cochrane Database Syst Rev. 2003;(3):CD001458
pubmed: 12917908
Eur J Vasc Endovasc Surg. 2018 Jan;55(1):3-81
pubmed: 28851594
J Vasc Surg. 2017 Dec;66(6):1727-1734.e2
pubmed: 28655552
Stroke. 2011 Aug;42(8):e464-540
pubmed: 21282493
J Vasc Surg. 2018 May;67(5):1419-1428
pubmed: 29242070
BMC Med Res Methodol. 2014 Jun 26;14:82
pubmed: 24965498
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
N Engl J Med. 2006 Oct 19;355(16):1660-71
pubmed: 17050890
Lancet. 2010 Mar 20;375(9719):985-97
pubmed: 20189239
Lancet. 2006 Oct 7;368(9543):1239-47
pubmed: 17027729
Lancet. 2008 Dec 20;372(9656):2132-42
pubmed: 19041130
N Engl J Med. 2010 Jul 1;363(1):11-23
pubmed: 20505173
Cochrane Database Syst Rev. 2001;(1):CD001921
pubmed: 11279740
Eur J Vasc Endovasc Surg. 2011 Feb;41(2):153-8
pubmed: 21269847
Lancet. 2004 Mar 20;363(9413):915-24
pubmed: 15043958
Lancet. 2010 Sep 25;376(9746):1062-73
pubmed: 20832852
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
CMAJ. 2012 May 15;184(8):895-9
pubmed: 22158397
Stroke. 2016 Nov;47(11):2783-2790
pubmed: 27738236
Lancet. 1998 May 9;351(9113):1379-87
pubmed: 9593407
Stroke. 2014 Feb;45(2):527-32
pubmed: 24347422

Auteurs

Christoph Knappich (C)

From the Department for Vascular and Endovascular Surgery (C.K., A.K., M.S., H.-H.E.), Klinikum rechts der Isar, Technical University of Munich, Germany.

Andreas Kuehnl (A)

From the Department for Vascular and Endovascular Surgery (C.K., A.K., M.S., H.-H.E.), Klinikum rechts der Isar, Technical University of Munich, Germany.

Bernhard Haller (B)

Institute of Medical Informatics, Statistics and Epidemiology (B.H.), Klinikum rechts der Isar, Technical University of Munich, Germany.

Michael Salvermoser (M)

From the Department for Vascular and Endovascular Surgery (C.K., A.K., M.S., H.-H.E.), Klinikum rechts der Isar, Technical University of Munich, Germany.

Ale Algra (A)

Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus and Julius Centre for Health Sciences and Primary Care (A.A.), University Medical Center Utrecht, the Netherlands.

Jean-Pierre Becquemin (JP)

Vascular Institute Paris East, Private Hospital Paul D'Egine, Ramsay Group, Champigny sur Marne, France (J.-P.B.).

Leo H Bonati (LH)

Department of Neurology and Stroke Center (L.H.B.), University Hospital Basel, Switzerland.
Department of Clinical Research (L.H.B.), University Hospital Basel, Switzerland.
Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, University College London, United Kingdom (L.H.B., M.M.B.).

Richard Bulbulia (R)

Clinical Trial Service Unit and Epidemiological Studies Unit (R.B., D.R.M.), Nuffield Department of Population Health, University of Oxford, United Kingdom.
Medical Research Council Population Health Research Unit (R.B.), Nuffield Department of Population Health, University of Oxford, United Kingdom.

David Calvet (D)

INSERM U1266, Paris, France (D.C., J.-L.M.).

Gustav Fraedrich (G)

Department of Vascular Surgery, Medical University of Innsbruck, Austria (G.F.).

John Gregson (J)

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, United Kingdom (J.G.).

Alison Halliday (A)

Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, United Kingdom (A.H.).

Jeroen Hendrikse (J)

Department of Radiology (J.H.), University Medical Center Utrecht, the Netherlands.

George Howard (G)

Department of Biostatistics, UAB School of Public Health, Birmingham, AL (G.H.).

Olav Jansen (O)

Department of Radiology and Neuroradiology, UKSH Campus Kiel, Germany (O.J.).

Mahmoud B Malas (MB)

Department of Surgery, Division of Vascular and Endovascular Surgery, University of California San Diego, Health System (M.B.M.).

Peter A Ringleb (PA)

Department of Neurology, University of Heidelberg Medical School, Germany (P.A.R.).

Martin M Brown (MM)

Department of Brain Repair and Rehabilitation, Stroke Research Centre, UCL Queen Square Institute of Neurology, University College London, United Kingdom (L.H.B., M.M.B.).

Jean-Louis Mas (JL)

INSERM U1266, Paris, France (D.C., J.-L.M.).

Thomas G Brott (TG)

Department of Neurology, Mayo Clinic, Jacksonville, FL (T.G.B.).

Dylan R Morris (DR)

Clinical Trial Service Unit and Epidemiological Studies Unit (R.B., D.R.M.), Nuffield Department of Population Health, University of Oxford, United Kingdom.

Steff C Lewis (SC)

Edinburgh Clinical Trials Unit, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, United Kingdom (S.C.L.).

Hans-Henning Eckstein (HH)

From the Department for Vascular and Endovascular Surgery (C.K., A.K., M.S., H.-H.E.), Klinikum rechts der Isar, Technical University of Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH